Insulin-like growth factor I stimulates tyrosine phosphorylation of p130Cas, focal adhesion kinase, and paxillin -: Role of phosphatidylinositol 3′-kinase and formation of a p130Cas•Crk complex

被引:90
作者
Casamassima, A
Rozengurt, E
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] Imperial Canc Res Fund, Lincolns Inn Fields, London WC2A 3PX, England
[3] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
D O I
10.1074/jbc.273.40.26149
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Addition of insulin growth factor-I (IGF-I) to quiescent Swiss 3T3 cells rapidly induced tyrosine phosphorylation of the p130Crk-associated substrate (p130(Cas)), a novel adaptor protein localized at focal adhesions. Half-maximal effect was obtained at 0.6 nM. IGF-I also promoted the formation of a complex between p130(Cas) and c-Crk and elicited a parallel increase in the tyrosine phosphorylation of p125(Fak) and paxillin. IGF-I-induced p130(Cas), p125Fak, and paxillin tyrosine phosphorylation could be dissociated from mitogen-activated protein kinase kinase, p70(S6K), and protein kinase C activation. In contrast, the structurally unrelated phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 markedly attenuated the increase in tyrosine phosphorylation of p130(Cas), p125(Fak) and paxillin induced by IGF-I. Cytochalasin D, which disrupts the network of actin microfilaments, completely prevented tyrosine phosphorylation of p130(Cas), p125(Fak), and paxillin and the formation of a p130(Cas).Crk complex in response to IGF-I. Thus, our results identified a phosphatidylinositol 3-kinase-dependent pathway that requires the integrity of the actin cytoskeleton to induce tyrosine phosphorylation of p130(Cas), p125(Fak) and paxillin in response to IGF-I and suggest that tyrosine phosphorylation of these focal adhesion proteins, together with the recruitment of c-Crk into a complex with p130(Cas), may play a novel role in IGF-I signal transduction.
引用
收藏
页码:26149 / 26156
页数:8
相关论文
共 79 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] AUVINEN M, 1995, MOL CELL BIOL, V15, P6513
  • [3] p125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors
    Baron, V
    Calléja, V
    Ferrari, P
    Alengrin, F
    Van Obberghen, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) : 7162 - 7168
  • [4] BASERGA R, 1995, CANCER RES, V55, P249
  • [5] Baserga R, 1997, VITAM HORM, V53, P65, DOI 10.1016/S0083-6729(08)60704-9
  • [6] The IGF-I receptor in cell growth, transformation and apoptosis
    Baserga, R
    Hongo, A
    Rubini, M
    Prisco, M
    Valentinis, B
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1332 (03): : F105 - F126
  • [7] INSULIN-LIKE GROWTH-FACTOR-I STIMULATES TYROSINE PHOSPHORYLATION OF ENDOGENOUS C-CRK
    BEITNERJOHNSON, D
    LEROITH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) : 5187 - 5190
  • [8] Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor
    Blakesley, VA
    Kalebic, T
    Helman, LJ
    Stannard, B
    Faria, TN
    Roberts, CT
    LeRoith, D
    [J]. ENDOCRINOLOGY, 1996, 137 (02) : 410 - 417
  • [9] INSULIN-LIKE GROWTH-FACTOR-I AND PLATELET-DERIVED GROWTH FACTOR-BB INDUCE DIRECTED MIGRATION OF HUMAN ARTERIAL SMOOTH-MUSCLE CELLS VIA SIGNALING PATHWAYS THAT ARE DISTINCT FROM THOSE OF PROLIFERATION
    BORNFELDT, KE
    RAINES, EW
    NAKANO, T
    GRAVES, LM
    KREBS, EG
    ROSS, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) : 1266 - 1274
  • [10] Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo
    Brooks, PC
    Klemke, RL
    Schon, S
    Lewis, JM
    Schwartz, MA
    Cheresh, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) : 1390 - 1398